ACURA PHARMACEUTICALS, INC
DelistedCIK 786947fmd_0Q9QYZNA8AJCA3SSSYM3B1TMKGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2021, 49 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 1 | 9 | 4 | 3 | 0 | 3 | 4 | 2 |
| Cost of revenue | – | 0 | 0 | – | – | – | – | – | – | – |
| Trading and principal transactions revenue | – | – | – | 0 | 0 | – | – | – | – | – |
| Gross profit | – | (0) | 1 | – | – | – | – | – | – | – |
| Research and development | 4 | 5 | 5 | 3 | 4 | 4 | 2 | 2 | 2 | 2 |
| Depreciation and amortization | 0 | 0 | 2 | – | – | – | – | – | – | – |
| Selling, general and administrative | 6 | 9 | 8 | 9 | 7 | 4 | 3 | 2 | 3 | 1 |
| Operating income | (10) | (14) | (12) | (4) | (7) | (5) | (4) | (1) | (1) | (1) |
| Interest expense | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 0 | 0 | (1) | (1) | (1) | (1) | 0 | – | – | – |
| Income before taxes | (10) | (14) | (13) | (5) | (7) | (6) | (4) | (4) | (1) | (1) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (10) | (14) | (13) | (5) | (7) | (32) | (4) | (4) | (1) | (1) |
| Net income | (10) | (14) | (13) | (5) | (7) | (6) | (4) | (4) | (1) | (1) |